한글목차

세계의 면역혈액학 시장 규모는 2019년에 20억 9,615만 달러에 달했습니다. 이 시장은 CAGR 3.00% 이상으로 2024년까지 성장하고 있습니다.

혈액 질환의 유병률 증가는 실적 기간 중 면역혈액학 시장의 성장에 기여했습니다. 혈액 질환의 유병률이 지속적으로 증가함에 따라 정밀한 혈액형 검사, 교차 매칭 검사, 선별 검사에 대한 수요가 증가하고 있습니다. 면역혈액학은 혈액형 항원 및 항체를 식별하고 수혈 및 장기 이식에서 적합성을 보장하기 위해 매우 중요합니다. 이 분야는 수혈 반응을 최소화하는 데 중요한 역할을 하므로 안전한 수혈을 지원하는 신뢰할 수 있는 면역혈액학 제품 및 서비스에 대한 수요가 증가하고 있습니다. 예를 들어 미국 국립 공중보건기관인 질병통제예방센터(Centers for Disease Control and Prevention)가 2024년 4월 발표한 보고서에 따르면 빈혈을 주요 진단명으로 내과를 찾은 환자 수는 280만 명, 사망자 수는 6,021명, 인구 10만 명당 사망률은 1.8명이었습니다. 따라서 혈액질환의 유병률 증가가 면역혈액학 시장의 성장을 촉진했습니다.

세계의 면역혈액학 시장에 대해 조사했으며, 시장의 개요와 제품별, 기술별, 질환별, 용도별, 최종사용자별, 지역·국가별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 개요

제2장 목차

제3장 표 리스트

제4장 도표

제5장 리포트 구성

제6장 시장의 특징

• 일반적인 시장의 정의
• 요약
• 면역혈액학 시장의 정의와 세분화
• 제품별 시장 세분화
  • 분석기와 시스템
  • 시약
• 기술별 시장 세분화
  • 바이오칩
  • 적혈구 자화 기술(Emt)
  • 젤 카드
  • 마이크로플레이트
  • 중합효소 연쇄 반응(PCR)
  • 기타
• 질환별 시장 세분화
  • 혈액 관련 질환
  • HIV(인간면역결핍바이러스)
  • 간염
• 용도별 시장 세분화
  • 수혈전 검사
  • 면역 용혈의 조사
  • 주산기 검사
  • 혈액형 분류
  • 백혈구와 혈소판 혈청학
• 최종사용자별 시장 세분화
  • 혈액은행
  • 진단·참조 검사실
  • 병원
  • 학술연구기관

제7장 주요 시장 동향

• 최첨단 자동화를 갖춘 차세대 혈액 처리 시스템
• 첨단 멀티플렉스 분석별 혈액검사 프로세스의 최적화

제8장 면역혈액학 시장 - 거시경제 시나리오

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2019-2024년
• 시장 성장 예측, 2024-2029년, 2034년

제10장 세계의 면역혈액학 시장 세분화

• 세계의 면역혈액학 시장, 제품별 세분화, 실적 및 예측, 2019-2024년, 2029년, 2034년
• 세계의 면역혈액학 시장, 기술별 세분화, 실적 및 예측, 2019-2024년, 2029년, 2034년
• 세계의 면역혈액학 시장, 질환별 세분화, 실적 및 예측, 2019-2024년, 2029년 예상, 2034년 예상
• 세계의 면역혈액학 시장, 용도별 세분화, 실적 및 예측, 2019-2024년, 2029년 예측, 2034년 예측
• 세계의 면역혈액학 시장, 최종사용자별 세분화, 실적 및 예측, 2019-2024년, 2029년 예상, 2034년 예상

제11장 면역혈액학 시장, 지역별 및 국가별 분석

• 세계의 면역혈액학 시장, 지역별, 실적 및 예측, 2019-2024년, 2029년 예상, 2034년 예상
• 세계의 면역혈액학 시장, 국가별, 실적 및 예측, 2019-2024년, 2029년 예상, 2034년 예상

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• QuidelOrtho Corporation
• Abbott Laboratories
• Grifols SA
• Bio-Rad Laboratories, Inc
• Danaher Corporation(Beckman Coulter, Inc.)

제20장 경쟁 벤치마킹

제21장 경쟁 대시보드

제22장 주요 합병과 인수

제23장 기회와 전략

• 2029년의 세계 면역혈액학 시장 - 가장 새로운 기회를 제공하는 국가
• 2029년의 세계 면역혈액학 시장 - 가장 새로운 기회를 제공하는 부문
• 2029년의 세계 면역혈액학 시장 - 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제24장 면역혈액학 시장, 결론·제안

제25장 부록

영문목차

Immunohematology refers to the branch of medicine and diagnostics that focuses on the study of blood group antigens and antibodies to ensure safe and effective blood transfusion and management of immune-mediated blood disorders. This field encompasses a range of diagnostic methods, devices and reagents used to analyze and identify blood types, detect antibodies and manage conditions related to the immune response involving blood cells.

The immunohematology market consists of sales, by entities (organizations, sole traders, or partnerships), of immunohematology that are utilized primarily when blood compatibility needs to be ensured, such as during pretransfusion testing, organ transplantation and investigation of immune-mediated hemolysis.

The global immunohematology market was valued at $2,096.15 million in 2019 which grew till 2024 at a compound annual growth rate (CAGR) of more than 3.00%.

Increasing Prevalence Of Blood Disorders

An increasing prevalence of blood disorders contributed to the growth of the immunohematology market in the historic period. As the prevalence of blood disorders continues to rise, the demand for precise blood typing, crossmatching and screening tests is expanding. Immunohematology is crucial for the identification of blood group antigens and antibodies, ensuring compatibility in blood transfusions and organ transplants. This field plays a vital role in minimizing transfusion reactions, thereby increasing the need for dependable immunohematology products and services to support safe transfusion practices. For instance, in April 2024, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health agency, there were 2.8 million visits to physician offices for anemia as the primary diagnosis, with 6,021 deaths, resulting in a mortality rate of 1.8 deaths per 100,000 population. Therefore, the increasing prevalence of blood disorders drove the growth of the immunohematology market.

Optimizing Blood Testing Processes With Advanced Multiplex Analysis

Companies operating in the immunohematology market focus on transforming blood transfusion management with advanced multiplex analysis. This technology enables high-resolution analysis of blood samples, allowing for more comprehensive and accurate results while reducing the need for multiple individual tests. It optimizes the testing process by grouping various parameters in one step, improving the efficiency and throughput of blood testing. For instance, in June 2024, Innobiochips, a France-based biotechnology company, introduced Omnys, an advanced solution designed to optimize blood transfusion, grouping and testing processes. This innovative system significantly improves laboratory efficiency by enabling multiplex analysis with high-resolution testing of blood components, such as ABO (major blood group system) /D typing (Rh factor) and phenotyping, while reducing the number of wells required from 16 to just 4-6. The Omnys incorporates multiple patented technologies, streamlining operations, minimizing waste and reducing the carbon footprint associated with blood testing. A beta testing program for Omnys is scheduled to begin in early 2025, offering blood banks and healthcare institutions an opportunity to assess its integration into transfusion workflows.

The global immunohematology market is fairly concentrated, with large players operating in the market. The top ten competitors in the market made up to 36.89% of the total market in 2023.

Immunohematology Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global immunohematology market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for immunohematology? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The immunohematology market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider immunohematology market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by disease, by application and by end user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the immunohematology market.
• Global Market Size And Growth- Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by technology, by disease, by application and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for immunohematology providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Analyzers And Systems; Reagents
• 2) By Technology: Biochips; Erythrocyte-Magnetized Technology (EMT); Gel Cards; Microplates; Polymerase Chain Reaction (PCR); Other Technologies
• 3) By Disease: Blood-Related Diseases; HIV (Human Immunodeficiency Viruses); Hepatitis
• 4) By Application: Pretransfusion Testing; Investigation Of Immune Hemolysis; Perinatal Testing; Blood Group Phenotyping; Leucocyte And Platelet Serology
• 5) By End User: Blood Banks; Diagnostic And Reference Laboratories; Hospitals; Academic And Research Institutes
• Companies Mentioned: QuidelOrtho Corporation (Ortho-Clinical Diagnostics); Abbott Laboratories; Grifols S.A.; BIO-RAD LABORATORIES, INC.; Beckman Coulter Inc. (Danaher Corporation)
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; immunohematology indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Immunohematology - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Immunohematology Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Analyzers And Systems
  • 6.4.2 Reagents
• 6.5 Market Segmentation By Technology
  • 6.5.1 Biochips
  • 6.5.2 Erythrocyte-Magnetized Technology (Emt)
  • 6.5.3 Gel Cards
  • 6.5.4 Microplates
  • 6.5.5 Polymerase Chain Reaction (PCR)
  • 6.5.6 Other Technologies
• 6.6 Market Segmentation By Disease
  • 6.6.1 Blood-Related Diseases
  • 6.6.2 HIV (Human immunodeficiency viruses)
  • 6.6.3 Hepatitis
• 6.7 Market Segmentation By Application
  • 6.7.1 Pretransfusion Testing
  • 6.7.2 Investigation Of Immune Hemolysis
  • 6.7.3 Perinatal Testing
  • 6.7.4 Blood Group Phenotyping
  • 6.7.5 Leucocyte And Platelet Serology
• 6.8 Market Segmentation By End User
  • 6.8.1 Blood Banks
  • 6.8.2 Diagnostic And Reference Laboratories
  • 6.8.3 Hospitals
  • 6.8.4 Academic And Research Institutes

7 Major Market Trends

• 7.1 Next-Generation Blood Processing System With Cutting-Edge Automation
• 7.2 Optimizing Blood Testing Processes With Advanced Multiplex Analysis

8 Immunohematology Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Immunohematology Market
• 8.2 Impact Of The War In Ukraine On The Immunohematology Market
• 8.3 Impact Of High Inflation On The Immunohematology Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2019 - 2024, Value ($ Million)
  • 9.2.1 Market Drivers 2019 - 2024
  • 9.2.2 Market Restraints 2019- 2024
• 9.3 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 9.3.1 Market Drivers 2024 - 2029
  • 9.3.2 Market Restraints 2024 - 2029

10 Global Immunohematology Market Segmentation

• 10.1 Global Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.2 Global Immunohematology Market, Segmentation By Technology, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.3 Global Immunohematology Market, Segmentation By Disease, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.4 Global Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 10.5 Global Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Immunohematology Market, Regional and Country Analysis

• 11.1 Global Immunohematology Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 11.2 Global Immunohematology Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.3 Asia-Pacific Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.4 Asia-Pacific Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.5 Asia-Pacific Immunohematology Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.9 China Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.10 China Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.11 India Market
• 12.12 India Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.13 India Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.14 India Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.17 Japan Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.18 Japan Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.21 Australia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.22 Australia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.25 Indonesia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.26 Indonesia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.29 South Korea Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 12.30 South Korea Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate tax structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.3 Western Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.4 Western Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.5 Western Europe Immunohematology Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.8 UK Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.9 UK Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.12 Germany Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.13 Germany Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.14 France Market
• 13.15 France Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.16 France Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.17 France Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.20 Italy Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.21 Italy Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.24 Spain Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 13.25 Spain Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Major companies
• 14.2 Eastern Europe Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.3 Eastern Europe Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.4 Eastern Europe Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.5 Eastern Europe Immunohematology Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.8 Russia Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 14.9 Russia Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.3 North America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.4 North America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.5 North America Immunohematology Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.9 USA Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.10 USA Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.13 Canada Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 15.14 Canada Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Investments
  • 16.1.12 Major Companies
• 16.2 South America Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.3 South America Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.4 South America Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.5 South America Immunohematology Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.8 Brazil Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 16.9 Brazil Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Major Companies
• 17.2 Middle East Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.3 Middle East Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 17.4 Middle East Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Immunohematology Market, Segmentation By Product, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 18.3 Africa Immunohematology Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
• 18.4 Africa Immunohematology Market, Segmentation By End User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 QuidelOrtho Corporation
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Abbott Laboratories
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Financial Overview
• 19.4 Grifols S.A.
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Bio-Rad Laboratories, Inc
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Danaher Corporation (Beckman Coulter, Inc.)
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Werfen S.A. Acquired Immucor, Inc. to Strengthen Specialized Diagnostics Portfolio
• 22.2 Quidel Corporation And Ortho Clinical Diagnostics Merger Strengthens Global In Vitro Diagnostics Leadership

23 Opportunities And Strategies

• 23.1 Global Immunohematology Market In 2029 - Countries Offering Most New Opportunities
• 23.2 Global Immunohematology Market In 2029 - Segments Offering Most New Opportunities
• 23.3 Global Immunohematology Market In 2029 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Immunohematology Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer